We have analysed the expression of transformationassociated viral antigens, the Epstein-Barr virus (EBV) DNA content and the phenotypic characteristics of two B95-8 virus-converted sublines of the EBV-negative Burkitt's lymphoma (BL) line BL28. The converted lines called E95A-BL28 and E95B-BL28, respectively, differed in their EBV gene expression. The E95B convertant expressed virus-encoded nuclear antigens EBNA1 to -6 and the membrane protein LMP1, but only EBNA2 and EBNA5 were detected by immunofluorescence and immunoblotting in the E95A convertant. Only the entire BamHI W, Y and H regions could be detected in the E95A convertant by hybridization of Southern blots with probes covering the BamHI C, W, Y, H, F, E, K and Nhet regions of the EBV genome. EBV episomes were found to be absent in the E95A convertant as seen by Gardella gels. The E95A convertant retained the phenotypic characteristics of the EBVnegative parental line, and remained highly clonable in agarose. In contrast, expression of EBNA1 to -6 and LMP1 was accompanied by a shift towards a more lymphoblastoid cell line-like phenotype and by loss of agarose clonability in the E95B convertant.
Epstein-Barr virus (EBV) is a potent transforming agent for B lymphocytes, giving rise to permanently growing lymphoblastoid cell lines (LCLs) which express six virus-encoded nuclear antigens, EBNA1 to -6 and two membrane proteins, LMP1 and LMP2 (Kieff & Liebowitz, 1989) . The EBV-transformed LCLs resemble normal B immunoblasts and express numerous activation markers but are always CD10-(CALLA) and CD77-(Burkitt's lymphoma-associated antigen) negative.
The functions of the transformation-associated viral proteins and their role in B cell immortalization are only poorly understood. EBNA1 binds to ori-P and maintains replication of the viral episomes (Yates et al., 1984) . The lack of transforming ability of the P3HR1 (Hinuma et al., 1967) and Daudi (Jones et al., 1984) EBV mutants, from which the EBNA2 encoding sequences are deleted, suggests that this gene is involved in immortalization and transformation of normal B cells. LMP1 transforms rodent cells (Wang et al., 1985) and contributes to morphological transformation of immortalized human keratinocytes (F~thraeus et al., 1990) .
Regardless of their EBV-carrying status, freshly isolated Burkitt's lymphoma (BL) cells are phenotypically similar. They express CD10 and CD77 but are deficient in B cell activation marker and adhesion molecules (Patarroyo et al., 1988) . EBV-carrying lines tend to drift towards an LCL-like phenotype upon culture in vitro. This is accompanied by a broadening of viral gene expression so that EBNA2 to -6 and LMPI are also detected . Since such phenotypic drift does not occur in EBV-negative lines, it must be due to EBV. This assumption was supported by the observation that the EBV conversion of EBV-negative BL lines often generated convertants with an LCL-like phenotype (Klein et al., 1983) .
EBV-transformed LCLs of normal B cell origin usually carry multiple episomal copies of the viral genome (Lindahl et al., 1974) . In contrast, in vitro EBV-converted sublines of EBV-negative B lymphoma lines often contain single integrated viral genomes (Hurley et aI., 1991 a) . The integration usually involves the terminal or adjacent regions of the viral genome, resulting in converted cell lines that express all EBNAs with or without LMP1 and LMP2 expression (Zimber-Strobl et al., 1991) .
In the course of studies aiming to characterize the effect of EBV conversion in the EBV-negative BL28 cell line, we have isolated an unusual convertant that expresses only EBNA2 and EBNA5. This convertant carries only the BamHI W, Y and H fragments of the EBV genome. The EBV-negative BL line BL28 and the lymphoblastoid cell line IARC 139 were established from a sporadic case of BL (Lenoir et al., 1985) . The EBVconverted sublines E95A-BL28 and E95B-BL28 were established by in vitro infection with the B95-8 EBV strain. One week after the infection, the BL28 cells were cloned by limiting dilution onto fibroblast feeder layers. Two of the resulting clones, E95A and E95B, were 100% EBNA-positive by anti-complement immunofluorescence (ACIF) staining (Reedman & Klein, 1973) . All the cell lines were maintained in RPMI 1640 medium supplemented with 10 % fetal calf serum (FCS), 100 units/ml penicillin and 100 ~tg/ml streptomycin.
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The EBNAs were detected by ACIF staining and immunoblotting using a polyvalent serum from a healthy EBV-seropositive donor (H.R. ; antibody titres against EBNA1 1:80, EBNA2a 1 : 160, EBNA2b 1:80, EBNA6 (a) Monoclonal antibodies PE-2 for EBNA2 (Young et al., 1989) and (b) JF-186 for ENBA5 (Finke et al., 1987) were used.
1:320). LMP1 was detected by immunoblotting using the monoclonal antibody S12 (Mann et al., 1985) . The proteins were separated by discontinuous gel electrophoresis (Laemmli, 1970) on a 7.5% polyacrylamide-SDS gel and blotted onto nitrocellulose filters (Schleicher & Schuell; Towbin et al., 1976) . The E95A and E95B convertants were found to be EBNA-positive by ACIF staining (not shown) and by immunoblotting of whole cell extracts probed with a polyvalent human serum. EBNA1, -3, -4 and -6, and LMP1 were detected in immunoblots of the E95B convertant and the reference B95-8 virus-containing LCL IARC 139. In contrast, the E95A convertant lacked EBNA1 and LMP1 expression ( Fig. 1 a, of the EBV genome cloned in pBR322 (a gift from Professor Lars Rymo, Gothenburg, Sweden) were excised with BamHI and electrophoresed on 0'8 % preparative agarose gels along with a 1.0 kb ladder DNA marker (Bio-Rad). The EBV fragments were purified from the gels and used as probes.
Genomic DNA was prepared from all the cell lines by standard procedures (Maniatis et al., 1982) . DNA (10 btg) was digested for 12 h with BamHI according to the manufacturer's specifications. The digested DNA was separated overnight on a 0.8 % agarose gel at 35 V and transferred to Hybond nylon membranes (Amersham). The EBV probes were labelled by random primer labelling (Boehringer Mannheim) and hybridized by standard techniques (Maniatis et al., 1982) .
In order to assess whether the coding sequences for EBV latent genes were present in the E95A convertant, BamHI-cleaved cellular DNA was probed with labelled EBV DNA fragments corresponding to the BamHI C, W, Y, H, F, E, K and Nhet regions (Fig. 3) . DNA preparations from the IARC 139 and the E95B cell lines were used as positive controls. The entire set of BamHI restriction fragments was detected in IARC 139 and the E95B convertant. DNA from the E95A convertant hybridized only with the BamHI W, Y and H fragments. Thus, the E95A convertant lacked the BamHI E, K and Nhet fragments which contain the coding exons for EBNA1, -3, -4 and -6, and LMP1 and -2. The failure to detect most of the EBV BamHI restriction fragments in the E95A convertant suggests that only a small part of the viral DNA is present in this cell line.
The 5' and 3' end integration may have taken place close to (within the 150 bp detection limits of the Southern blotting technique) or at the BamHI W-W and H-F junction because we could not detect any aberrant fragment resulting from the fusion of viral and cellular DNA sequences (Fig. 3) .
The E95A convertant is the first example of an EBVcarrying cell that lacks the expression of EBNA1. Since EBNA1 is essential for EBV episomal maintenance and the absence of terminal repeats precludes circularization, we inferred that the fragment carried by the E95A convertant must be integrated. In order to check this, the Gardella gel technique was carried out essentially as described (Gardella et al., 1984) . A 0"75 % agarose gel was prepared. The area above the slots was removed and replaced with a 0'8 % agarose gel containing 2% SDS and 1 mg/ml pronase. Then 1 x l 0 G (Raji), 2x l0 G (Namalwa, B95-8) or 3 x l0 G (BL28, E95A, E95B and IARC 139) ceils were placed in the wells. The E95A ceils indeed lacked any episomal EBV, as shown in Fig. 4 . The Raji cells showed unusually high levels of linear DNA; this signal could be due to high amounts of broken DNA.
The expression of the B cell activation/differentiation markers was assessed by indirect immunofluorescence using monoclonal antibodies for different surface markers as shown in Table 1 . Briefly, 1 x l0 G cells were incubated with antibodies for 60 min on ice. After washing twice with PBS, the fluorescein isothiocyanateconjugated second antibody was spread over the cell pellet for 1 h. The cells were washed twice in PBS and counted immediately in a fluorescence-activated cell sorting 420 analyser (Becton-Dickinson). As seen in Table 1 , the E95B convertant showed an LCL-like phenotype, closely similar to that of the IARC 139 control. In contrast, the E95A convertant showed a group I phenotype. Thus, the E95A line expressed high levels of C A L L A and ICAM-1 but did not express CD23, CD39, LFA-1 or LFA-3.
The capacity to form colonies in semi-solid agarose was tested as described previously (Torsteindottir et al., 1989) . Briefly, peripheral blood lymphocytes, obtained from heparinized blood of healthy donors, were pulsed with phytohaemagglutinin, irradiated (3000 rads) and mixed with 0.45% (w/v) Seaplaque agarose (Maine Colloids Laboratory) heated and diluted in R P M ! 1640 supplemented with 10 % FCS. Cell suspension (1.5 x 10" cells/dish) was distributed (3 ml/dish) in 35 x 10 m m Petri dishes. When the underlayer had solidified, the dishes were incubated at 37 °C in a 5 % CO~ atmosphere for 24 h. Agarose solution, 3 ml at 0"35% (w/v) in complete medium, was mixed with the cells at 40 °C and poured on the top of the agarose underlayer. One-thousand cells were seeded on each dish. Cloning efficiency was estimated after 7 or 8 days of culture at 37 °C. A group of more than 20 cells was scored as a clone.
The E95A convertant cloned as efficiently as the parental BL28 in this assay. In contrast, the E95B convertant had lost the capacity to grow in soft agar (Table 2) .
Our findings confirm the previous observation by Hurley et al. (1991 a) that in vitro EBV infection of EBVnegative BE lines often results in converted sublines which carry integrated viral genomes. In the lines investigated by these authors, the integration appeared to occur most frequently through the viral terminal repeats. In three out of six convertants o f the BL41 line carrying integrated viral genomes, integration was accompanied by deletion o f the B a m H I C fragment. As in the E95A cell line described here, no aberrant fragments resulting from the junction o f the viral and cellular D N A could be detected in these cells.
In vitro EBV-transformed LCLs usually contain viral genomes in episomal form and evidence o f integration has been difficult to obtain. Two exceptions to this have been reported so far, the IB4 (Hurley et al., 1991b) and R G N 1 LCLs (Gualandi et al., 1992) . The IB4 L C L carries approximately four integrated viral genomes and expresses the L M P 2 protein encoded by a spliced m R N A from the terminal repeat region. Thus, integration must have occurred after circularization of the EBV genome. In the RGN1 LCL, the integration involves the ori-P region which becomes linked to human DNA repeat sequences. Hurley & Thorley-Lawson (1988) have shown that covalently closed viral episomes are formed at a very early stage after EBV infection of resting B cells, i.e. before the initiation of cellular DNA synthesis. This suggests that the circularization of the viral genome may require factors that are present in resting cells. Conversely, viral integration may be favoured if the infected cells are already proliferating.
We found that in spite of the expression of EBNA2 and EBNA5 the E95A convertant has remained phenotypically similar to EBV-negative BL cells. This failure to undergo phenotypic progression is not due to inherent properties of the BL28 cell line because the E95B convertant showed extensive phenotypic changes including the loss of ability to clone in agarose. It is important to note that the E95A convertant appeared to be even more restricted into a group I phenotype than the parental BL28 cells since the latter but not the former showed upregulation of the HLA All allele after prolonged culture in vitro. We do not know whether the lack of progression in the E95A cell line is at all related to its limited expression of viral antigens. Both EBNA2 and EBNA5 are required for transformation and their expression provides transfected human and murine cells with growth advantages (Mannick et al., 1991 , Dambaugh et al., 1986 .
The demonstration that a very short piece of EBV DNA may become integrated within the cellular DNA suggests that the conventional criterion used for defining EBV positivity, namely EBNA staining, may not be sufficient to judge the EBV carrier status of a cell. It seems advisable to test critically important lymphomas not only for EBNA and LMP expression, but also for the presence of EBV DNA fragments.
